Alejandro Villalba

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Rheumatoid Arthritis Patients

Ejection Fraction

Top Venues

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Novella Navarro, Virginia Ruiz-Esquide, Natalia López-Juanes, Chafik Alejandro Chacur, Irene Monjo Henry, Laura Nuño, Diana Peiteado, Alejandro Villalba, Elisa Fernández-Fernandez, María Sanz-Jardón, Mónica Kafati, Raimon Sanmartí, Chamaida Plasencia-Rodriguez, Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical rheumatology 43 (9) (2024)
Marta Novella Navarro, Virginia Ruiz-Esquide, Natalia López-Juanes, Chafik Alejandro Chacur, Irene Monjo Henry, Laura Nuño, Diana Peiteado, Alejandro Villalba, Elisa Fernández-Fernandez, María Sanz-Jardón, Mónica Kafati, Raimon Sanmartí, Chamaida Plasencia-Rodriguez, Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical rheumatology 43 (9) (2024)
Marta Novella Navarro, Virginia Ruiz-Esquide, Natalia López-Juanes, Chafik Alejandro Chacur, Irene Monjo Henry, Laura Nuño, Diana Peiteado, Alejandro Villalba, Elisa Fernández-Fernandez, María Sanz-Jardón, Mónica Kafati, Raimon Sanmartí, Chamaida Plasencia-Rodriguez, Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical rheumatology 43 (9) (2024)
Marta Novella Navarro, Virginia Ruiz-Esquide, Natalia López-Juanes, Chafik Alejandro Chacur, Irene Monjo Henry, Laura Nuño, Diana Peiteado, Alejandro Villalba, Elisa Fernández-Fernandez, María Sanz-Jardón, Mónica Kafati, Raimon Sanmartí, Chamaida Plasencia-Rodriguez, Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical rheumatology (2024)